AstraZeneca says no supply snags so far from Red Sea disruptions
Drugmaker AstraZeneca has not seen any supply issues so far due to Red Sea shipping disruptions, a top executive told Reuters ahead of the World Economic Forum on Monday. We have...
Stay updated with breaking news from Eva Mathews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugmaker AstraZeneca has not seen any supply issues so far due to Red Sea shipping disruptions, a top executive told Reuters ahead of the World Economic Forum on Monday. We have...
British lender Metro Bank on Friday said its chief financial officer James Hopkinson would leave the company during the first quarter of 2024. ...
The European Union's drug watchdog said on Friday it started a review into the safety risks associated with cancer cell therapies made by companies such as Novartis and Gilead Sciences. ...
Shares in the FTSE midcap firm were up 7% at 359.1 pence at 0849 GMT, and were among top gainers across all London stocks. The company expects fiscal year 2024 revenue to grow between 23% and 24.5%, compared to 22%-23.5% earlier, while it sees adjusted core profit margin of 18%-20%, compared with 17%-19% previously. Amid macroeconomic challenges, the potential for new business ARR "appears to have stabilised but not yet materially improved", Darktrace added.
British landlord LondonMetric Property will acquire London-based real estate investment trust LXI in a deal valued at 1.9 billion pounds , the companies said on Thursday. (Reporting by Eva Mathews in...